THC — Tenet Healthcare Corporation

Tenet Healthcare Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Net Operating Revenues: $5.4 billion
• Consolidated Adjusted EBITDA: $1.16 billion (21.6% margin)
• USPI Adjusted EBITDA: $484 million (36.7% margin, 6% growth YoY)
• Hospital Segment Adjusted EBITDA: $678 million (16.7% margin)
• Free Cash Flow: $978 million
• Share Repurchases: 1.35 million shares for $318 million
• Cash Position: $2.97 billion with no debt under the line of credit

2. Strategic Updates and Business Highlights:

• USPI experienced a 5.3% growth in same-facility revenues, driven by a significant increase in total joint replacements.
• The company invested $125 million in acquiring 7 ASCs and opened 3 new centers, completing half of its annual M&A target in Q1.
• The hospital segment's performance was bolstered by disciplined expense management and growth initiatives, despite challenges from payer mix and exchange enrollment.
• Tenet is implementing technology investments, including AI and automation, to improve operational efficiency and clinical throughput.

3. Forward Guidance and Outlook:

• Tenet reaffirmed its full-year 2026 guidance, expecting adjusted EBITDA to grow by 10% at the midpoint.
• For Q2 2026, adjusted EBITDA is expected to be 24%-25% of the full-year target.
• The company anticipates adjusted free cash flow for the year to be between $1.6 billion and $1.83 billion, factoring in tax payments related to the Conifer transaction.

4. Bad News, Challenges, or Points of Concern:

• Payer Mix and Exchange Enrollment: There has been a decline in exchange coverage, with same-store exchange admissions down about 10% YoY, contributing to revenue pressures.
• Uncompensated Care: There is speculation regarding increased uncompensated care due to the expiration of exchange subsidies, although Tenet has not seen a significant impact on hospital operations.
• Volume Challenges: The hospital segment experienced a 41% drop in respiratory admissions, which negatively affected overall admissions growth.
• Payer Denials: There is a noted increase in payer disputes and denials, although Tenet has not seen a significant change in net impact compared to previous quarters.

5. Notable Q&A Insights:

• Management acknowledged high payer denial rates but noted no significant changes in their business compared to prior periods.
• The company is focused on maintaining operational discipline and flexibility in response to market changes, particularly in managing costs effectively.
• There is cautious optimism regarding potential shifts from exchange coverage to commercial insurance, which could mitigate some risks.
• Tenet's leadership emphasized the importance of technology and operational efficiencies as key drivers for future growth, especially in high-acuity service lines.

Overall, Tenet Healthcare reported a strong start to 2026, with solid financial performance and strategic initiatives aimed at enhancing operational efficiency and growth, despite facing challenges related to payer dynamics and market conditions.